PMC:7003341 / 47562-48044 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T124","span":{"begin":61,"end":83},"obj":"Disease"}],"attributes":[{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"}],"text":"First, oxygen therapy is the choice for patients with severe respiratory infections, respiratory distress, hypoxemia or shock. The initial flow rate is 5 L/min, and the titration flow rate is to reach the target oxygen saturation (adults: SpO2 ≥ 90% in non-pregnant patients, SpO2 ≥ 92–95% in pregnant patients; children: SpO2 ≥ 94% in children with obstructive dyspnea, apnea, severe respiratory distress, central cyanosis, shock, coma or convulsions, and ≥ 90% in other children)."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T353","span":{"begin":329,"end":331},"obj":"http://purl.obolibrary.org/obo/CLO_0001527"}],"text":"First, oxygen therapy is the choice for patients with severe respiratory infections, respiratory distress, hypoxemia or shock. The initial flow rate is 5 L/min, and the titration flow rate is to reach the target oxygen saturation (adults: SpO2 ≥ 90% in non-pregnant patients, SpO2 ≥ 92–95% in pregnant patients; children: SpO2 ≥ 94% in children with obstructive dyspnea, apnea, severe respiratory distress, central cyanosis, shock, coma or convulsions, and ≥ 90% in other children)."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T93","span":{"begin":7,"end":13},"obj":"Chemical"},{"id":"T94","span":{"begin":212,"end":218},"obj":"Chemical"}],"attributes":[{"id":"A93","pred":"chebi_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A94","pred":"chebi_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"}],"text":"First, oxygen therapy is the choice for patients with severe respiratory infections, respiratory distress, hypoxemia or shock. The initial flow rate is 5 L/min, and the titration flow rate is to reach the target oxygen saturation (adults: SpO2 ≥ 90% in non-pregnant patients, SpO2 ≥ 92–95% in pregnant patients; children: SpO2 ≥ 94% in children with obstructive dyspnea, apnea, severe respiratory distress, central cyanosis, shock, coma or convulsions, and ≥ 90% in other children)."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T105","span":{"begin":61,"end":83},"obj":"Phenotype"},{"id":"T106","span":{"begin":85,"end":105},"obj":"Phenotype"},{"id":"T107","span":{"begin":107,"end":116},"obj":"Phenotype"},{"id":"T108","span":{"begin":120,"end":125},"obj":"Phenotype"},{"id":"T109","span":{"begin":362,"end":369},"obj":"Phenotype"},{"id":"T110","span":{"begin":371,"end":376},"obj":"Phenotype"},{"id":"T111","span":{"begin":385,"end":405},"obj":"Phenotype"},{"id":"T112","span":{"begin":415,"end":423},"obj":"Phenotype"},{"id":"T113","span":{"begin":425,"end":430},"obj":"Phenotype"},{"id":"T114","span":{"begin":432,"end":436},"obj":"Phenotype"}],"attributes":[{"id":"A105","pred":"hp_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/HP_0011947"},{"id":"A106","pred":"hp_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A107","pred":"hp_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/HP_0012418"},{"id":"A108","pred":"hp_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/HP_0031273"},{"id":"A109","pred":"hp_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A110","pred":"hp_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/HP_0002104"},{"id":"A111","pred":"hp_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A112","pred":"hp_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/HP_0000961"},{"id":"A113","pred":"hp_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/HP_0031273"},{"id":"A114","pred":"hp_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/HP_0001259"}],"text":"First, oxygen therapy is the choice for patients with severe respiratory infections, respiratory distress, hypoxemia or shock. The initial flow rate is 5 L/min, and the titration flow rate is to reach the target oxygen saturation (adults: SpO2 ≥ 90% in non-pregnant patients, SpO2 ≥ 92–95% in pregnant patients; children: SpO2 ≥ 94% in children with obstructive dyspnea, apnea, severe respiratory distress, central cyanosis, shock, coma or convulsions, and ≥ 90% in other children)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T377","span":{"begin":0,"end":126},"obj":"Sentence"},{"id":"T378","span":{"begin":127,"end":238},"obj":"Sentence"},{"id":"T379","span":{"begin":239,"end":321},"obj":"Sentence"},{"id":"T380","span":{"begin":322,"end":482},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"First, oxygen therapy is the choice for patients with severe respiratory infections, respiratory distress, hypoxemia or shock. The initial flow rate is 5 L/min, and the titration flow rate is to reach the target oxygen saturation (adults: SpO2 ≥ 90% in non-pregnant patients, SpO2 ≥ 92–95% in pregnant patients; children: SpO2 ≥ 94% in children with obstructive dyspnea, apnea, severe respiratory distress, central cyanosis, shock, coma or convulsions, and ≥ 90% in other children)."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"744","span":{"begin":40,"end":48},"obj":"Species"},{"id":"745","span":{"begin":266,"end":274},"obj":"Species"},{"id":"746","span":{"begin":302,"end":310},"obj":"Species"},{"id":"747","span":{"begin":312,"end":320},"obj":"Species"},{"id":"748","span":{"begin":336,"end":344},"obj":"Species"},{"id":"749","span":{"begin":472,"end":480},"obj":"Species"},{"id":"750","span":{"begin":7,"end":13},"obj":"Chemical"},{"id":"751","span":{"begin":212,"end":218},"obj":"Chemical"},{"id":"752","span":{"begin":61,"end":83},"obj":"Disease"},{"id":"753","span":{"begin":85,"end":105},"obj":"Disease"},{"id":"754","span":{"begin":107,"end":125},"obj":"Disease"},{"id":"755","span":{"begin":350,"end":369},"obj":"Disease"},{"id":"756","span":{"begin":371,"end":376},"obj":"Disease"},{"id":"757","span":{"begin":385,"end":405},"obj":"Disease"},{"id":"758","span":{"begin":415,"end":423},"obj":"Disease"},{"id":"759","span":{"begin":425,"end":430},"obj":"Disease"},{"id":"760","span":{"begin":432,"end":436},"obj":"Disease"},{"id":"761","span":{"begin":440,"end":451},"obj":"Disease"}],"attributes":[{"id":"A744","pred":"tao:has_database_id","subj":"744","obj":"Tax:9606"},{"id":"A745","pred":"tao:has_database_id","subj":"745","obj":"Tax:9606"},{"id":"A746","pred":"tao:has_database_id","subj":"746","obj":"Tax:9606"},{"id":"A747","pred":"tao:has_database_id","subj":"747","obj":"Tax:9606"},{"id":"A748","pred":"tao:has_database_id","subj":"748","obj":"Tax:9606"},{"id":"A749","pred":"tao:has_database_id","subj":"749","obj":"Tax:9606"},{"id":"A750","pred":"tao:has_database_id","subj":"750","obj":"MESH:D010100"},{"id":"A751","pred":"tao:has_database_id","subj":"751","obj":"MESH:D010100"},{"id":"A752","pred":"tao:has_database_id","subj":"752","obj":"MESH:D012141"},{"id":"A753","pred":"tao:has_database_id","subj":"753","obj":"MESH:D012128"},{"id":"A754","pred":"tao:has_database_id","subj":"754","obj":"MESH:D000860"},{"id":"A755","pred":"tao:has_database_id","subj":"755","obj":"MESH:D004417"},{"id":"A756","pred":"tao:has_database_id","subj":"756","obj":"MESH:D001049"},{"id":"A757","pred":"tao:has_database_id","subj":"757","obj":"MESH:D012128"},{"id":"A758","pred":"tao:has_database_id","subj":"758","obj":"MESH:D003490"},{"id":"A759","pred":"tao:has_database_id","subj":"759","obj":"MESH:D012769"},{"id":"A760","pred":"tao:has_database_id","subj":"760","obj":"MESH:D003128"},{"id":"A761","pred":"tao:has_database_id","subj":"761","obj":"MESH:D012640"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"First, oxygen therapy is the choice for patients with severe respiratory infections, respiratory distress, hypoxemia or shock. The initial flow rate is 5 L/min, and the titration flow rate is to reach the target oxygen saturation (adults: SpO2 ≥ 90% in non-pregnant patients, SpO2 ≥ 92–95% in pregnant patients; children: SpO2 ≥ 94% in children with obstructive dyspnea, apnea, severe respiratory distress, central cyanosis, shock, coma or convulsions, and ≥ 90% in other children)."}